RadNet (RDNT) Stock Price, News & Analysis $36.00 -0.22 (-0.61%) (As of 03:57 PM ET) Add Compare Share Share Today's Range$35.22▼$36.3150-Day Range$25.42▼$36.4852-Week Range$17.82▼$36.73Volume205,058 shsAverage Volume430,963 shsMarket Capitalization$2.48 billionP/E RatioN/ADividend YieldN/APrice Target$34.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability RadNet MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside5.2% Downside$34.00 Price TargetShort InterestBearish3.17% of Shares Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment0.76Based on 10 Articles This WeekInsider TradingSelling Shares$451,427 Sold Last QuarterProj. Earnings Growth-14.29%From $0.42 to $0.36 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.63 out of 5 starsMedical Sector807th out of 944 stocksMedical Laboratories Industry18th out of 19 stocks 1.5 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $34.00, RadNet has a forecasted downside of 5.2% from its current price of $35.87.Amount of Analyst CoverageRadNet has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.17% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in RadNet has recently increased by 1.39%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 2.6 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for RadNet this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $451,427.00 in company stock.Percentage Held by InsidersOnly 4.43% of the stock of RadNet is held by insiders.Percentage Held by Institutions74.84% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to decrease by -14.29% in the coming year, from $0.42 to $0.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -3,583.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -3,583.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 4.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About RadNet Stock (NASDAQ:RDNT)RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More RDNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDNT Stock News HeadlinesDecember 11, 2023 | americanbankingnews.comTruist Financial Increases RadNet (NASDAQ:RDNT) Price Target to $42.00December 8, 2023 | finance.yahoo.comInsider Sell Alert: EVP & Chief Development Officer Michael Murdock Sells 10,115 Shares of ...December 11, 2023 | Edge On The Street (Ad)U.S. Military Defense Fails Without Vanadium?The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply. December 5, 2023 | msn.comLightning Round: I'm sticking behind RadNet, says Jim CramerDecember 5, 2023 | finance.yahoo.comRadNet Launches a Pilot Inside Walmart of its New MammogramNow™ OfferingNovember 27, 2023 | finance.yahoo.comRadNet, Inc. to Present at the BofA Securities 2023 Leveraged Finance Conference on November 28, 2023November 27, 2023 | finance.yahoo.comRadNet Unveils DeepHealth, a Pioneering AI-Powered Health Informatics PortfolioNovember 26, 2023 | benzinga.comMaverick Medical AI Partners with RadNet to Launch AI-powered Medical Coding Across U.S. Imaging SitesDecember 11, 2023 | Edge On The Street (Ad)U.S. Military Defense Fails Without Vanadium?The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles. And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply. November 15, 2023 | finance.yahoo.comShould You Be Concerned About RadNet, Inc.'s (NASDAQ:RDNT) ROE?November 15, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Thursday, November 16thNovember 10, 2023 | insidermonkey.comRadNet, Inc. (NASDAQ:RDNT) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | markets.businessinsider.comRadnet’s Robust Performance and Growth Prospects Justify Macdonald’s Buy RatingNovember 8, 2023 | markets.businessinsider.comWhat Wall Street expects from RadNet's earningsNovember 8, 2023 | finance.yahoo.comRadNet Reports Third Quarter Financial Results and Revises Upwards 2023 Financial Guidance Range for Adjusted EBITDANovember 1, 2023 | morningstar.comRadNet Inc RDNTOctober 27, 2023 | finance.yahoo.comShould Value Investors Buy RadNet (RDNT) Stock?October 26, 2023 | finance.yahoo.comInstitutional investors may overlook RadNet, Inc.'s (NASDAQ:RDNT) recent US$148m market cap drop as long-term gains remain positiveOctober 17, 2023 | finance.yahoo.comRadNet, Inc. Announces Date of its Third Quarter 2023 Financial Results Conference CallOctober 5, 2023 | finance.yahoo.comInvestors in RadNet (NASDAQ:RDNT) have seen favorable returns of 87% over the past five yearsSeptember 20, 2023 | finance.yahoo.comRadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Wednesday, September 20thAugust 31, 2023 | finance.yahoo.comBe Wary Of RadNet (NASDAQ:RDNT) And Its Returns On CapitalAugust 24, 2023 | markets.businessinsider.comJim Cramer Says This Major Telecom Stock Is 'Horrendous'August 8, 2023 | finance.yahoo.comRadNet (RDNT) Q2 Earnings and Revenues Top EstimatesAugust 8, 2023 | benzinga.comA Preview Of RadNet's EarningsAugust 8, 2023 | finance.yahoo.comRadNet Reports Second Quarter Financial Results, with Record Quarterly Revenue and Adjusted EBITDA(1), and Updates 2023 Financial Guidance RangesJuly 31, 2023 | finance.yahoo.comRadNet, Inc. Announces the Addition of Sham Sokka and Sanjog Misra to Drive Further Growth Within its Digital Health InitiativesSee More Headlines Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2023Today12/11/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees9,067Year Founded1980Price Target and Rating Average Stock Price Target$34.00 High Stock Price Target$42.00 Low Stock Price Target$30.00 Potential Upside/Downside-4.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio84.93 P/E GrowthN/ANet Income$10.65 million Net Margins0.25% Pretax Margin2.49% Return on Equity4.16% Return on Assets1.03% Debt Debt-to-Equity Ratio1.06 Current Ratio1.42 Quick Ratio1.42 Sales & Book Value Annual Sales$1.58 billion Price / Sales1.56 Cash Flow$3.51 per share Price / Cash Flow10.17 Book Value$8.57 per share Price / Book4.16Miscellaneous Outstanding Shares68,995,000Free Float65,939,000Market Cap$2.46 billion OptionableOptionable Beta1.79 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Howard G. Berger M.D. (Age 77)Chairman, President & CEO Comp: $5.56MMr. Mark D. Stolper (Age 52)Executive VP & CFO Comp: $1.13MMr. Mital Patel (Age 37)Executive VP of Financial Planning & Analysis and Chief Administrative Officer Comp: $1.15MMr. Norman R. Hames (Age 67)President & COO of Western Operations Comp: $1.28MMr. Stephen M. Forthuber (Age 62)President & COO of Eastern Operations Comp: $1.3MMs. Christine Nayoma Gordon (Age 60)Senior VP of Operations - Northern California & Director Comp: $384.38kMr. Ranjan Jayanathan (Age 67)Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division Dr. Gregory Sorensen M.D. (Age 61)Executive VP, Chief Science Officer & Director Ms. Laura Foster BSRTMPH, J.D., Senior Vice President of Compliance & Regulatory AffairsMr. David Jeffrey Katz (Age 58)Executive VP, Chief Legal Officer & Corporate Secretary More ExecutivesKey CompetitorsFortreaNASDAQ:FTREVeracyteNASDAQ:VCYTGuardant HealthNASDAQ:GHViridian TherapeuticsNASDAQ:VRDNFulgent GeneticsNASDAQ:FLGTView All CompetitorsInsiders & InstitutionsCitigroup Inc.Sold 10,617 shares on 12/6/2023Ownership: 0.166%Michael N MurdockSold 10,115 sharesTotal: $354,227.30 ($35.02/share)Wellington Management Group LLPBought 622,008 shares on 12/1/2023Ownership: 0.916%American Century Companies Inc.Sold 144,133 shares on 11/30/2023Ownership: 1.102%Christine Nayoma GordonSold 3,000 sharesTotal: $97,200.00 ($32.40/share)View All Insider TransactionsView All Institutional Transactions RDNT Stock Analysis - Frequently Asked Questions Should I buy or sell RadNet stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price target for 2024? 3 analysts have issued 1-year price targets for RadNet's shares. Their RDNT share price targets range from $30.00 to $42.00. On average, they predict the company's stock price to reach $34.00 in the next twelve months. This suggests that the stock has a possible downside of 5.2%. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2023? RadNet's stock was trading at $18.83 at the start of the year. Since then, RDNT shares have increased by 90.5% and is now trading at $35.87. View the best growth stocks for 2023 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our RDNT earnings forecast. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) released its earnings results on Wednesday, November, 8th. The medical research company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.08. The medical research company had revenue of $401.97 million for the quarter, compared to analysts' expectations of $391.63 million. RadNet had a net margin of 0.25% and a trailing twelve-month return on equity of 4.16%. The firm's revenue was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.09 earnings per share. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH) and First Trust Small Cap Growth AlphaDEX Fund (FYC).iShares U.S. Healthcare Providers ETF (IHF). What guidance has RadNet issued on next quarter's earnings? RadNet updated its FY 2023 earnings guidance on Wednesday, November, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.60 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). Who are RadNet's major shareholders? RadNet's stock is owned by a number of institutional and retail investors. Top institutional investors include Invesco Ltd. (2.17%), Principal Financial Group Inc. (1.71%), Punch & Associates Investment Management Inc. (1.54%), American Century Companies Inc. (1.10%), Loomis Sayles & Co. L P (0.97%) and Northern Trust Corp (0.95%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:RDNT) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.